Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F. Guigonis V, et al. Among authors: llanas b. Pediatr Nephrol. 2008 Aug;23(8):1269-79. doi: 10.1007/s00467-008-0814-1. Epub 2008 May 9. Pediatr Nephrol. 2008. PMID: 18465150 Clinical Trial.
Rituximab therapy for childhood-onset systemic lupus erythematosus.
Willems M, Haddad E, Niaudet P, Koné-Paut I, Bensman A, Cochat P, Deschênes G, Fakhouri F, Leblanc T, Llanas B, Loirat C, Pillet P, Ranchin B, Salomon R, Ulinski T, Bader-Meunier B; French Pediatric-Onset SLE Study Group. Willems M, et al. Among authors: llanas b. J Pediatr. 2006 May;148(5):623-627. doi: 10.1016/j.jpeds.2006.01.041. J Pediatr. 2006. PMID: 16737873
High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis: potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations.
Tory K, Lacoste T, Burglen L, Morinière V, Boddaert N, Macher MA, Llanas B, Nivet H, Bensman A, Niaudet P, Antignac C, Salomon R, Saunier S. Tory K, et al. Among authors: llanas b. J Am Soc Nephrol. 2007 May;18(5):1566-75. doi: 10.1681/ASN.2006101164. Epub 2007 Apr 4. J Am Soc Nephrol. 2007. PMID: 17409309
Acute renal cortical necrosis due to acquired antiprotein S antibodies.
Larakeb AS, Evrard S, Louillet F, Kwon T, Djaffar H, Llanas B, Deschênes G, Hurtaud-Roux MF, Baudouin V. Larakeb AS, et al. Among authors: llanas b. Pediatr Nephrol. 2009 Jan;24(1):207-9. doi: 10.1007/s00467-008-0967-y. Epub 2008 Sep 6. Pediatr Nephrol. 2009. PMID: 18777044
Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1.
Fargue S, Harambat J, Gagnadoux MF, Tsimaratos M, Janssen F, Llanas B, Berthélémé JP, Boudailliez B, Champion G, Guyot C, Macher MA, Nivet H, Ranchin B, Salomon R, Taque S, Rolland MO, Cochat P. Fargue S, et al. Among authors: llanas b. Kidney Int. 2009 Oct;76(7):767-73. doi: 10.1038/ki.2009.237. Epub 2009 Jul 1. Kidney Int. 2009. PMID: 19571789 Free article.
Adenine phosphoribosyltransferase deficiency in children.
Harambat J, Bollée G, Daudon M, Ceballos-Picot I, Bensman A; APRT Study Group. Harambat J, et al. Pediatr Nephrol. 2012 Apr;27(4):571-9. doi: 10.1007/s00467-011-2037-0. Epub 2012 Jan 3. Pediatr Nephrol. 2012. PMID: 22212387
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
Tellier S, Brochard K, Garnier A, Bandin F, Llanas B, Guigonis V, Cailliez M, Pietrement C, Dunand O, Nathanson S, Bertholet-Thomas A, Ichay L, Decramer S. Tellier S, et al. Among authors: llanas b. Pediatr Nephrol. 2013 Jun;28(6):911-8. doi: 10.1007/s00467-012-2406-3. Epub 2013 Jan 23. Pediatr Nephrol. 2013. PMID: 23340857
84 results